Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis (MS)”

1,083 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,083 results

Early research (Phase 1)UnknownNCT02200718
What this trial is testing

NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Immune Response BioPharma, Inc. 12
Not applicableLooking for participantsNCT05258396
What this trial is testing

Exploring Cortical Remyelination in Children With Multiple Sclerosis

Who this might be right for
Children With Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 40
Not applicableStudy completedNCT03603691
What this trial is testing

Study to Evaluate the Reliability and Validity of the Modified Manual Muscle Test for Persons With MS

Who this might be right for
Multiple Sclerosis
Nanco van der Maas 28
Not applicableStudy completedNCT05890885
What this trial is testing

MS Fatigue and tDCS on Fatigue in Multiple Sclerosis

Who this might be right for
Fatigue in Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 10
Not applicableActive Not RecruitingNCT05781113
What this trial is testing

A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition

Who this might be right for
Multiple Sclerosis
Celestra Health Systems 90
Not applicableStudy completedNCT01978574
What this trial is testing

Intellectual Enrichment to Build Cognitive Reserve in MS

Who this might be right for
Cognitive Impairment in Multiple Sclerosis
Kessler Foundation 9
Not applicableNot Yet RecruitingNCT07310862
What this trial is testing

Virtual Reality - Gamma Sensory Stimulation for Improving Fatigue in People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Clarity Health Technologies, Inc 30
Testing effectiveness (Phase 2)Study completedNCT00489489
What this trial is testing

Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 118
Early research (Phase 1)Looking for participantsNCT05539729
What this trial is testing

Vancomycin Study in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Icahn School of Medicine at Mount Sinai 12
Not applicableUnknownNCT04977622
What this trial is testing

Gray Matter Demyelination in Primary Progressive MS at 7T

Who this might be right for
Primary Progressive Multiple Sclerosis
Danish Research Centre for Magnetic Resonance 60
Not applicableEnded earlyNCT03808545
What this trial is testing

Activity and Balanced Eating to Reduce Comorbidities and Symptoms of MS

Who this might be right for
Multiple Sclerosis
University of Alabama at Birmingham 11
Not applicableStudy completedNCT02636829
What this trial is testing

Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory Arthritis

Who this might be right for
Multiple SclerosisRheumatoid Arthritis
Centre Hospitalier Universitaire de Nīmes 100
Testing effectiveness (Phase 2)Ended earlyNCT01228266
What this trial is testing

Mesenchymal Stem Cell Transplantation in MS

Who this might be right for
Multiple Sclerosis
Albert Saiz 9
Not applicableStudy completedNCT04441229
What this trial is testing

Mobile Attentional Bias Modification Training in Pediatric MS

Who this might be right for
Pediatric Multiple Sclerosis
NYU Langone Health 37
Post-approval studies (Phase 4)Study completedNCT02048072
What this trial is testing

Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS

Who this might be right for
Multiple SclerosisAutonomic Nervous System Dysfunction
Jochen Vehoff 33
Not applicableStudy completedNCT00906737
What this trial is testing

Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities

Who this might be right for
Multiple Sclerosis
Mount Sinai Rehabilitation Hospital 18
Post-approval studies (Phase 4)UnknownNCT04048577
What this trial is testing

A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Berkovich, Regina MD, PhD Inc. 10
Not applicableStudy completedNCT04115930
What this trial is testing

Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients

Who this might be right for
Relapsing Remitting Multiple SclerosisFatigueQuality of Life+1 more
University of Eastern Finland 61
Not applicableNot Yet RecruitingNCT07474129
What this trial is testing

Serious Game Rehabilitation and Brain Plasticity in MS

Who this might be right for
Multiple Sclerosis (MS)
Lille Catholic University 40
Large-scale testing (Phase 3)Study completedNCT03599245
What this trial is testing

This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Hoffmann-La Roche 1,055
Load More Results